Skip to main content
. 2020 Dec 18;11:588151. doi: 10.3389/fneur.2020.588151

Table 3.

TEE-findings in all 485 patients, in all patients with cryptogenic etiology and with cryptogenic etiology in different age groups.

All patients n = 485 Cryptogenic etiology n = 329 <55 years n = 86 ≥55 and <75 years n = 161 ≥75 years n = 82
Endocarditis,
no (%)
3 (0.6%) 1 (0.3%) 0 (0.0%) 0 (0.0%) 1 (1.2%)
SEC, no (%) 34 (7.0%) 7 (2.1%) 0 (0.0%) 1 (0.6%) 6 (7.3%)
Vmax LAA ≤30cm/s, no (%) 19 (3.9%) 3 (0.9%) 0 (0.0%) 1 (0.6%) 2 (2.4%)
LA/LAA-thrombus, no (%) 3 (0.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
PFO, no (%) 44 (9.1%) 34 (10.3%) 21 (24.4%) 10 (6.2%) 3 (3.7%)
ASA, no (%) 23 (4.7%) 17 (5.2%) 2 (2.3%) 4 (2.5%) 11 (13.4%)
PFO plus ASA,
no (%)
91 (18.8%) 64 (19.5%) 18 (20.9%) 32 (19.9%) 14 (17.1%)
ASD, no (%) 6 (1.2%) 5 (1.5%) 4 (4.7%) 1 (0.6%) 0 (0.0%)
Aortic plaque <4 mm,
no (%)
316 (65.2%) 204 (62.0%) 13 (15.1%) 120 (74.5%) 71 (86.6%)
Aortic Arch plaque ≥4 mm,
no (%)
113 (23.1%) 72 (21.6%) 2 (1.2%), 37 (23.0%) 33 (40.2%)
Aorta descendens plaque ≥4 mm, no (%) 197 (40.6%) 126 (38.1%) 4 (3.5%) 72 (44.7%) 50 (60.1%)
Aortic thrombus, no (%) 16 (3.3%) 12 (3.6%) 0 (0.0%) 5 (3.1%) 7 (8.5%)

Please note that all aortic plaques shown here include plaques of the proximal descending aorta. SEC, spontaneous echo contrast; Vmax-LAA, maximal left atrial appendage velocity; LAA/LA, left atrial appendage/left atrium; PFO, patent foramen ovale; ASA, atrial septum aneurysm; ASD, atrial septum defect.